TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005% OMNI BY OSRX Trademark

Trademark Overview


On Thursday, May 9, 2019, a trademark application was filed for TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005% OMNI BY OSRX with the United States Patent and Trademark Office. The USPTO has given the TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005% OMNI BY OSRX trademark a serial number of 88423698. The federal status of this trademark filing is REGISTERED as of Tuesday, May 11, 2021. This trademark is owned by OSRX, Inc.. The TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005% OMNI BY OSRX trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic preparations containing TIMOLOL, BRIMONIDINE TARTRATE, DORZOLAMIDE, and LATANOPROST
timolol / brimonidine tartrate / dorzolamide / latanoprost ophthalmic solution 0.5% / 0.2% / 2% / 0.005% omni by osrx

General Information


Serial Number88423698
Word MarkTIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005% OMNI BY OSRX
Filing DateThursday, May 9, 2019
Status700 - REGISTERED
Status DateTuesday, May 11, 2021
Registration Number6348820
Registration DateTuesday, May 11, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"TIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION 0.5% / 0.2% / 2% / 0.005%"
Description of MarkThe mark consists of the words "Timolol / Brimonidine Tartrate / Dorzolamide / Latanoprost Ophthalmic Solution 0.5% / 0.2% / 2% / 0.005%" above the words of "OMNI by OSRX". The "Timolol / Brimonidine Tartrate / Dorzolamide / Latanoprost Ophthalmic Solution" words are above the "0.5% / 0.2% / 2% / 0.005%" language. The word "OMNI" is above the words "by OSRX". The lettering for "OMNI" is larger than the lettering for "by OSRX". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI" and ending to the right of the "X" in "OSRX". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".
Goods and ServicesOphthalmic preparations containing TIMOLOL, BRIMONIDINE TARTRATE, DORZOLAMIDE, and LATANOPROST
Pseudo MarkTIMOLOL / BRIMONIDINE TARTRATE / DORZOLAMIDE / LATANOPROST OPHTHALMIC SOLUTION ZERO POINT FIVE PERCENT / ZERO POINT TWO PERCENT / TWO PERCENT / ZERO POINT ZERO ZERO FIVE PERCENT OMNI BY OSRX

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 24, 2019
Primary Code005
First Use Anywhere DateWednesday, May 1, 2019
First Use In Commerce DateWednesday, May 1, 2019

Trademark Owner History


Party NameOSRX, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMissoula, MT 59801

Party NameOSRX, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMissoula, MT 59801

Party NameOSRX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMissoula, MT 59801

Trademark Events


Event DateEvent Description
Tuesday, May 11, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, April 7, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 6, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 5, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 6, 2020NON-FINAL ACTION E-MAILED
Tuesday, October 6, 2020SU - NON-FINAL ACTION - WRITTEN
Friday, October 2, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 17, 2020USE AMENDMENT FILED
Friday, October 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 17, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 29, 2020ASSIGNED TO LIE
Friday, January 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 25, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 25, 2019NON-FINAL ACTION E-MAILED
Thursday, July 25, 2019NON-FINAL ACTION WRITTEN
Wednesday, July 24, 2019ASSIGNED TO EXAMINER
Saturday, May 25, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 13, 2019NEW APPLICATION ENTERED IN TRAM